Overview

Monoclonal gammopathy of undetermined significance (MGUS) is a condition in which an atypical protein is found in the blood. The protein is called monoclonal protein or M protein.

This protein is made in the soft, blood-producing tissue in the center of bones. This blood-producing tissue is bone marrow. Monoclonal gammopathy of undetermined significance occurs most often in older men.

MGUS usually causes no problems. But sometimes it can lead to more-serious diseases. These include some forms of blood cancer.

People who have high amounts of this protein in the blood need regular checkups. That's so they can get earlier treatment if the condition gets worse. If it doesn't get worse, MGUS doesn't need treatment.

Symptoms

People with monoclonal gammopathy often don't have symptoms. Some people have a rash or nerve problems, such as numbness or tingling. A blood test for another condition might find MGUS by chance.

Causes

Experts don't know what causes MGUS. Changes in genes and being around certain chemicals, such as those used to kill pests, appear to play a role.

Risk factors

Factors that increase your risk of developing MGUS include:

  • Age. The average age at diagnosis is 70 years.
  • Race. Africans and Black Americans are more likely to get MGUS than white people are.
  • Sex. MGUS is more common in men.
  • Family history. Having family members with MGUS might increase the risk.

Complications

Each year, about 1% of people with MGUS get certain types of blood cancers or other serious diseases, such as:

  • Multiple myeloma.
  • Light chain amyloidosis.
  • Waldenstrom macroglobulinemia.
  • Lymphoma.

Other issues linked to MGUS include broken bones, blood clots, kidney problems, and damage to nerves outside of the brain and spinal cord, also known as peripheral neuropathy.

Sept. 10, 2024

Living with monoclonal gammopathy of undetermined significance (mgus)?

Connect with others like you for support and answers to your questions in the Blood Cancers & Disorders support group on Mayo Clinic Connect, a patient community.

Blood Cancers & Disorders Discussions

beanglow
What was your experience with bone marrow biopsy?

115 Replies Thu, Oct 31, 2024

Lori, Volunteer Mentor
My Bone Marrow Transplant (BMT/SCT) story: Will you share yours?

521 Replies Thu, Oct 31, 2024

shenriq
Essential Thrombocythemia: Looking for information and support

594 Replies Thu, Oct 31, 2024

See more discussions
  1. Goldman L, et al., eds. Plasma cell disorders. In: Goldman-Cecil Medicine. 26th ed. Elsevier; 2020. https://www.clinicalkey.com. Accessed Jan. 6, 2023.
  2. Ferri FF. Monoclonal gammopathy of undetermined significance (MGUS). In: Ferri's Clinical Advisor 2023. Elsevier; 2023. https://www.clinicalkey.com. Accessed Jan. 6, 2023.
  3. Monoclonal gammopathy of undetermined significance (MGUS). Merck Manual Professional Version. https://www.merckmanuals.com/professional/hematology-and-oncology/plasma-cell-disorders/monoclonal-gammopathy-of-undetermined-significance-mgus?query=mgus#. Accessed April 6, 2023.
  4. Laubach JP. Diagnosis of monoclonal gammopathy of undetermined significance. https://www.uptodate.com/contents/search. Accessed Jan. 6, 2023.
  5. Rajhumar SV. Clinical course and management of monoclonal gammopathy of undetermined significance. https://www.uptodate.com/contents/search. Accessed Jan. 6, 2023.
  6. AskMayoExpert. Monoclonal gammopathy of undetermined significance (MGUS) (adult). Mayo Clinic; 2021.
  7. Ami TR. Allscripts EPSi. Mayo Clinic. Feb. 1, 2023.
  8. Pruthi RK (expert opinion). Mayo Clinic. April 26, 2019.

Related

Associated Procedures

Products & Services

Monoclonal gammopathy of undetermined significance (MGUS)